FOLFIRINOX Improves PFS Compared with Gemcitabine in Patients with Locally Advanced Pancreatic Carcinoma By Ogkologos - May 26, 2025 598 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PRODIGE 29-UCGI 26 (NEOPAN) study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Researchers May Be Able to Predict Breast Cancer Metastasis by Changes... December 3, 2021 Groundbreaking Physicist Uses Laser Technology To Kill Cancer Cells Without Any... June 9, 2020 Breast Cancer Survivor Driven from Her Home by Noxious Gases from... June 11, 2021 Radio Hosts Test Sanity For Charity By Listening to ‘Baby Shark’... November 20, 2019 Load more HOT NEWS New Safety Signal for Use of Ibrutinib in Combination with Rituximab... Failed Alzheimer’s Drug Might Boost CAR T-Cell Therapy for Multiple Myeloma Cross-Border Network of European Specialists Provides New Treatment Options For Women... Rapid Genetic Test Could Help Guide Brain Cancer Surgery
